Ltr Pharma Fpo has released a press release.
TGA Provides Regulatory Clearance for SPONTAN Phase II
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from LTR Pharma
- Ethics Approval Received for SPONTAN Phase II Clinical Study
- LTR increases LevOmega stake to 43% with $1m investment
- LTR Pharma secures 33% ownership in LevOmega Pty Ltd
- FY25 Results Announcement
- Appendix 4E and Annual Report to Shareholders
Later from LTR Pharma
- First Patients Dosed in SPONTAN Phase II Clinical Study
- Quarterly Activities/Appendix 4C Cash Flow Report
- SPONTAN Shows Positive Outcomes in Younger Men with ED
- Appendix 4D and Half Yearly Report
- SPONTAN Phase II Clinical Study Completes Recruitment
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma